Enyo Pharma
4 known investors
ENYO Pharma is a clinical-stage biopharmaceutical company developing therapeutics for patients with impaired kidney function. Its lead compound, VONAFEXOR, is a small molecule with fibrolytic and anti-inflammatory properties in Phase 2 development for rare kidney disease Alport Syndrome and Chronic Kidney Diseases.</parameter> <parameter name="founders">[]
BiotechMedical Devices
Investors · 4
In the news
Frequently asked questions
- What does Enyo Pharma do?
- ENYO Pharma is a clinical-stage biopharmaceutical company developing therapeutics for patients with impaired kidney function. Its lead compound, VONAFEXOR, is a small molecule with fibrolytic and anti-inflammatory properties in Phase 2 development for rare kidney disease Alport Syndrome and Chronic Kidney Diseases.</parameter> <parameter name="founders">[]
- Who are Enyo Pharma's investors?
- Enyo Pharma's investors include Andera Partners, OrbiMed, Sofinnova Partners, Bpifrance.